Analysts' Top Healthcare Picks: Avid Bioservices (CDMO), LifeMD (LFMD)

TipRanksApr 16 20:40

Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)

TipRanksApr 1 20:36

Avid Bioservices Announces Receipt of Deficiency Notice From Nasdaq Regarding Late Form 10-Q

TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the

GlobeNewswireMar 20 19:00

Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages...

Stockhouse Mar 17 19:00

Avid Bioservices Is Maintained at Overweight by Stephens & Co.

Avid Bioservices Is Maintained at Overweight by Stephens & Co.

Dow JonesMar 11 23:10

Stephens & Co. Maintains Overweight on Avid Bioservices, Lowers Price Target to $12

Stephens & Co. analyst Jacob Johnson maintains Avid Bioservices with a Overweight and lowers the price target from $15 to $12.

Analyst UpgradesMar 11 23:00